Skip to main content

Table 2 Blood count parameters (mean ± SD) acquired at end of second and fourth weeks of I+G mice with or without statin therapy

From: Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy

 

LEUK (109/L)

ERY (1012/L)

HGB (g/dl)

NEU (109/L)

LYM (109/L)

MONO (109/L)

PLT (109/L)

2wks

       

C

8.79 ± 1.98

8.27 ± 0.33

13.98 ± 0.61

1.44 ± 0.13

8.89 ± 1.54

0.07 ± 0.06

1330.33 ± 45.88

I

8.20 ± 3.19

9.09 ± 0.88

15.80 ± 1.18

1.21 ± 0.37

6.07 ± 2.61

0.71 ± 0.28†

1167.78 ± 87.37

I+G

12.07 ± 0.9*

8.36 ± 0.51

14.28 ± 0.65

2.07 ± 0.22*

7.68 ± 2.16

0.72 ± 0.07†

1277.33 ± 34.08

I+G+St

8.15 ± 1.77‡

7.53 ± 0.26

13.63 ± 1.01

2.81 ± 0.87‡

5.22 ± 1.23‡

0.62 ± 0.03

1025.25 ± 420.78

4wks

       

C

9.93 ± 2.76

9.35 ± 0.28

16.08 ± 0.77

1.75 ± 0.18

6.46 ± 1.47

0.19 ± 0.02

1514.4 ± 76.51

I

19.1 ± 5.18†

9.36 ± 0.04

15.60 ± 0.01

11.50 ± 0.14†

7.39 ± 0.36

1.68 ± 0.56*

1455.2 ± 129.67

I+G

25.02 ± 2.53†

8.26 ± 0.27

15.46 ± 0.29

11.06 ± 1.05†

9.37 ± 1.59*

2.26 ± 0.32†

1313.8 ± 120.34*

I+G+St

18.86 ± 3.45‡

8.40 ± 0.26

15.7 ± 0.58

9.51 ± 0.61‡

5.88 ± 1.31‡

1.27 ± 0.59‡

1433.7 ± 156.18

  1. LEUK, leukocytes; ERY, erythrocytes; HGB, hemoglobin; NEU, neutrophil; LYM, lymphocyte; MONO, monocyte; PLT, platelet; *p < 0.05, †p < 0.01 vs control; ‡ p < 0.05 vs I+G, n = 8 in each group.